Table 2.
Cancer secondary to immunosuppression
Increased risk under anti-metabolites | Increased risk under anti-TNFα | Increased risk under anti-metabolite with anti-TNFα |
Non-Hodgkin lymphoma[33-35] | Melanoma[42] | Hepatosplenic T-cell lymphoma[38] |
Acute myeloid leukemia and Myelodysplastic syndromes[61] | ||
Non-melanoma skin cancers (basal and squamous cell carcinomas)[39-41] | ||
Urinary tract cancers[62] |
TNF-α: Tumor necrosis factor alpha.